Cited 0 time in
Associated Brain Parenchymal Abnormalities in Developmental Venous Anomalies: Evaluation with Susceptibility-weighted MR Imaging
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 류현규 | - |
| dc.contributor.author | 최대섭 | - |
| dc.contributor.author | 조수범 | - |
| dc.contributor.author | 신화선 | - |
| dc.contributor.author | 최호철 | - |
| dc.contributor.author | 정보슬 | - |
| dc.contributor.author | 서혜민 | - |
| dc.contributor.author | 조재민 | - |
| dc.date.accessioned | 2022-12-26T22:17:34Z | - |
| dc.date.available | 2022-12-26T22:17:34Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.issn | 2384-1095 | - |
| dc.identifier.issn | 2384-1109 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/17953 | - |
| dc.description.abstract | Purpose: The purpose of this study was to evaluate the associated brain parenchymalabnormalities of developmental venous anomalies (DVA) with susceptibility-weightedimage (SWI). Materials and Methods: Between January 2012 and June 2013, 2356 patientsunderwent brain MR examinations with contrast enhancement. We retrospectivelyreviewed their MR examinations and data were collected as per the following criteria:incidence, locations, and associated parenchymal signal abnormalities of DVAs onT2-weighted image, fluid-attenuated inversion recovery (FLAIR), and SWI. Contrastenhanced T1-weighted image was used to diagnose DVA. Results: Of the 2356 patients examined, 57 DVAs were detected in 57 patients(2.4%); 47 (82.4%) were in either lobe of the supratentorial brain, 9 (15.7%) were inthe cerebellum, and 1 (1.7%) was in the pons. Of the 57 DVAs identified, 20 (35.1%)had associated parenchymal abnormalities in the drainage area. Among the 20 DVAswhich had associated parenchymal abnormalities, 13 showed hemorrhagic foci onSWI, and 7 demonstrated only increased parenchymal signal abnormalities on T2-weighted and FLAIR images. In 5 of the 13 patients (38.5%) who had hemorrhagicfoci, the hemorrhagic lesions were demonstrated only on SWI. Conclusion: The overall incidence of DVAs was 2.4%. Parenchymal abnormalitieswere associated with DVAs in 35.1% of the cases. On SWI, hemorrhage wasdetected in 22.8% of DVAs. Thus, we conclude that SWI might give a potential forunderstanding of the pathophysiology of parenchymal abnormalities in DVAs. | - |
| dc.format.extent | 7 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | 대한자기공명의과학회 | - |
| dc.title | Associated Brain Parenchymal Abnormalities in Developmental Venous Anomalies: Evaluation with Susceptibility-weighted MR Imaging | - |
| dc.title.alternative | Associated Brain Parenchymal Abnormalities in Developmental Venous Anomalies: Evaluation with Susceptibility-weighted MR Imaging | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.13104/imri.2015.19.3.146 | - |
| dc.identifier.bibliographicCitation | Investigative Magnetic Resonance Imaging, v.19, no.3, pp 146 - 152 | - |
| dc.citation.title | Investigative Magnetic Resonance Imaging | - |
| dc.citation.volume | 19 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 146 | - |
| dc.citation.endPage | 152 | - |
| dc.identifier.kciid | ART002036425 | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.subject.keywordAuthor | Cerebral developmental venous anomaly | - |
| dc.subject.keywordAuthor | Hemorrhage | - |
| dc.subject.keywordAuthor | MR | - |
| dc.subject.keywordAuthor | Susceptibilityweighted imaging (SWI) | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
